BR0106261A - Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids - Google Patents

Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids

Info

Publication number
BR0106261A
BR0106261A BR0106261-1A BR0106261A BR0106261A BR 0106261 A BR0106261 A BR 0106261A BR 0106261 A BR0106261 A BR 0106261A BR 0106261 A BR0106261 A BR 0106261A
Authority
BR
Brazil
Prior art keywords
coronaridine
aids
treatment
compositions containing
relates
Prior art date
Application number
BR0106261-1A
Other languages
English (en)
Inventor
Dumith Chequer Bou-Habib
Bernardo Galvao Castro
Edinete Melo Da Silva
Elvira Maria Saraiva Bou-Habib
Martin Khuene
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Priority to BR0106261-1A priority Critical patent/BR0106261A/pt
Priority to PCT/BR2002/000193 priority patent/WO2003059343A2/en
Priority to AU2002357417A priority patent/AU2002357417A1/en
Publication of BR0106261A publication Critical patent/BR0106261A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçõES MEDICAMENTOSAS CONTENDO ALCALóIDES INDóLICOS PARA O TRATAMENTO DA AIDS". A presente invenção refere-se ao uso de alcalóides indólicos do tipo iboga, em especial coronaridina e seu derivado 18-metóxi coronaridina, na preparação de medicamentos capazes de inibir a ação do vírus HIV. Uma das concretizações da presente invenção se relaciona a uma composição farmacêutica para tratamento da AIDS, contendo coronaridina e um veículo farmaceuticamente aceitável. Outra concretização da presente invenção refere-se a uma composição farmacêutica para tratamento da AIDS, contendo análogos da coronaridina, em especial o 18-metóxi coronaridina e um veículo farmaceuticamente aceitável.
BR0106261-1A 2001-12-26 2001-12-26 Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids BR0106261A (pt)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BR0106261-1A BR0106261A (pt) 2001-12-26 2001-12-26 Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids
PCT/BR2002/000193 WO2003059343A2 (en) 2001-12-26 2002-12-26 Drug compositions with indole alkaloids for the treatment of aids
AU2002357417A AU2002357417A1 (en) 2001-12-26 2002-12-26 Drug compositions with indole alkaloids for the treatment of aids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0106261-1A BR0106261A (pt) 2001-12-26 2001-12-26 Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids

Publications (1)

Publication Number Publication Date
BR0106261A true BR0106261A (pt) 2003-09-02

Family

ID=3948179

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0106261-1A BR0106261A (pt) 2001-12-26 2001-12-26 Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids

Country Status (3)

Country Link
AU (1) AU2002357417A1 (pt)
BR (1) BR0106261A (pt)
WO (1) WO2003059343A2 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013063673A1 (pt) * 2011-11-04 2013-05-10 Hebron Farmacêutica Pesquisa, Desenvolvimento E Inovação Tecnológica Ltda. Composição farmacêutica e seu uso

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629307A (en) * 1989-10-20 1997-05-13 Olney; John W. Use of ibogaine in reducing excitotoxic brain damage
MX9701430A (es) * 1994-07-25 1997-12-31 Nda Int Inc Un metodo de tratamiento de dependencia quimica en mamiferos y una composicion para el mismo.
WO1997005869A1 (en) * 1995-08-08 1997-02-20 Albany Medical College Ibogamine congeners

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013063673A1 (pt) * 2011-11-04 2013-05-10 Hebron Farmacêutica Pesquisa, Desenvolvimento E Inovação Tecnológica Ltda. Composição farmacêutica e seu uso

Also Published As

Publication number Publication date
WO2003059343A2 (en) 2003-07-24
AU2002357417A1 (en) 2003-07-30
WO2003059343A3 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
BR0108435A (pt) Formulação e uso de entecavir de baixa dose
AR025959A1 (es) DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
BR0213522A (pt) Composto, composição farmacêutica, métodos de inibir a hiv integrase e para prevenir ou tratar a infecção pelo hiv ou para prevenir, tratar ou retardar o inìcio da aids em um paciente, e, combinação útil para tratar ou prevenir a infecção pelo hiv ou para prevenir, tratar ou retardar o inìcio da aids
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
BRPI0008228B8 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
SE9901573D0 (sv) New compounds
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
WO2002034267A8 (de) Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen
KR970061244A (ko) 치매 치료용 약학 조성물
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
NZ324380A (en) Therapeutic benzimidazole compounds and their use in treatment of virus infections
BRPI0407140A (pt) Droga terapêutica para vìrus
UY26595A1 (es) Formulaciones de entecavir de dosis bajas y uso
SE9901572D0 (sv) New compounds
BR0106261A (pt) Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids
ATE192926T1 (de) Flavopereirine enthaltende zusammensetzung und ihre anwendung in der behandlung gegen hiv-viren
RU2011113733A (ru) Производные 1-амино-алкилциклогексана для лечения когнитивного нарушения при шуме в ушах
BR0014233A (pt) Conjugados de 4-benzilaminoquinolina com ácido galênico e seus heteroanálogos, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação
AR030551A1 (es) Uso de nefiracetam para la fabricacion de un medicamento para eltratamiento de la neurodegeneracion y composicion farmaceutica resultante
YU25202A (sh) Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera
BR0009327A (pt) Composição farmacêutica para a terapia de sintomas do trato urinário inferior
BR0114339A (pt) Composições farmaceuticamente aceitáveis contendo epinastina e pseudoefedrina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]